|Cancer||Cell death||Cell cycle||Cytoskeleton||Exo/endocytosis||Differentiation||Division||Organelles||Signalling||Stem cells||Trafficking|
Cell Biology International (2003) 27, 953958 (Printed in Great Britain)
Bcl-2 antisense oligodeoxynucleotide increases the sensitivity of leukemic cells to arsenic trioxide
Y Zhang* and W.L Shen
Institute of Hematology, Medical College of Jinan University, Guangzhou 510632, China
Cell culture, tissue chemistry and flow cytometry were used to determine whether antisense bcl-2 oligodeoxynucleotides enhanced the sensitivity of leukemia cells to arsenic trioxide. A combination of arsenic trioxide with antisense bcl-2 oligodeoxynucleotides inhibited cell growth, induced apoptosis and induced bcl-2 protein expression in K562 and NB4 leukemic cells more significantly than either arsenic trioxide or the oligodeoxynucleotides on their own (P<0.01). Thus, bcl-2 antisense oligodeoxynucleotides increase the sensitivity of leukemic cells to arsenic trioxide. Combined use of the two agents could be a novel and attractive strategy in leukemia treatment.
Key words: bcl-2, Apoptosis, Arsenic trioxide, Leukemia, Antisense oligonucleotide.
*Corresponding author. Tel.: +86-20-8522-6476; fax: +86-20-8522-1343
Received 24 January 2002/26 May 2003; accepted 8 July 2003doi:10.1016/S1065-6995(03)00164-1